Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Milting
Prevention of Pulmonary Vascular and Myocardial Remodeling by the Combined Tyrosine and Serine-/Threonine Kinase Inhibitor, Sorafenib, in Pulmonary Hypertension and Right Heart Failure
European Respiratory Review
Pulmonary
Respiratory Medicine
Related publications
Tyrosine Kinase Inhibitor–Induced Pulmonary Arterial Hypertension
Advances in Pulmonary Hypertension
Treatment of Pulmonary Hypertension Caused by Left Heart Failure With Pulmonary Arterial Hypertension-Specific Therapies: Lessons From the Right and LEPHT
Circulation
Cardiovascular Medicine
Physiology
Cardiology
EXPRESS: Right Heart in Pulmonary Hypertension: From Adaptation to Failure
Pulmonary Circulation
Pulmonary
Respiratory Medicine
Vascular Remodeling in Pulmonary Arterial Hypertension: Roles of CaSR and PDGF
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Diffuse Right Ventricular Fibrosis in Heart Failure With Preserved Ejection Fraction and Pulmonary Hypertension
ESC heart failure
Cardiovascular Medicine
Cardiology
Sildenafil Attenuates Pulmonary Vascular Remodeling and Upregulates Kv1.5 mRNA Expression in Pulmonary Hypertension Secondary to Left-To-Right Shunt in Rats
Critical Care
Critical Care
Intensive Care Medicine
P11 Tyrosine Kinase Inhibitor Use in Pulmonary Adenocarcinoma
Thorax
Pulmonary
Respiratory Medicine
S120 Right Ventricular Dysfunction in Pulmonary Hypertension With Combined Pulmonary Fibrosis and Emphysema Syndrome
Thorax
Pulmonary
Respiratory Medicine
Hemodialysis With Ultrafiltration for Right Heart Failure Due to Pulmonary Hypertension
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
